Skip to main content

IL-6 Knockout Mice

  • Chapter
Cytokine Knockouts

Part of the book series: Contemporary Immunology ((CONTIM))

  • 449 Accesses

Summary

Interleukin-6 (IL-6) is a pleiotropic cytokine thought to play important regulatory roles in immunity, hemopoiesis, and inflammation (reviewed in ref. 1). The generation of IL-6-deficient mice by gene targeting has allowed direct testing of its role in a variety of physiological and pathological conditions. Thus, IL-6 has been shown to favour the resolution of infections and to promote optimal humoral responses to various antigens while at the same time being required for the development of immune-mediated diseases, such as CIA or EAE, as well as of diseases such as osteoporosis and plasmacytomas, caused by improper expansion of specific hematopietic compartments. In addition, IL-6-deficient mice display defective liver acute phase and regenerative responses, improper body weight regulation, impaired neuronal regeneration, and altered nociceptive responses, confirming the pleiotropic nature of this cytokine. This chapter attempts to review the ample literature in the field by trying to rationalize the main conclusions achieved and to highlight the open-ended problems.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kishimoto, T. (1989) The biology of interleukin-6. Blood 74, 1 - 10.

    PubMed  CAS  Google Scholar 

  2. Gauldie, J., Richards, C., Harnish, D., Lansdorp, P., and Baumann, H. (1987) Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc. Natl. Acad. Sci. USA 84, 7251 - 7255.

    PubMed  CAS  Google Scholar 

  3. Behrmann, I., Hermanns, H. M., Haan, C., et al. (2000) Signalling of interleukin-6 type cytokines via gp130, leukemia inhibitory factor (LIE) receptor and oncostatin M receptor. Eur. Cytokine Netw. 11, 491 - 492.

    PubMed  CAS  Google Scholar 

  4. Jones, S. A., Horiuchi, S., Topley, N., Yamamoto, N., and Fuller, G. M. (2001) The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J. 15, 43 - 58.

    PubMed  CAS  Google Scholar 

  5. Hirano, T., Nakajima, K., and Hibi, M. (1997) Signaling mechanisms through gp130: a model of the cytokine system. Cytokine Growth Factor Rev. 8, 241 - 252.

    PubMed  CAS  Google Scholar 

  6. Kopf, M., Baumann, H., Freer, G., et al. (1994) Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368, 339 - 342.

    PubMed  CAS  Google Scholar 

  7. Poli, V., Balena, R., Fattori, E., et al. (1994) Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 13, 1189 - 1196.

    PubMed  CAS  Google Scholar 

  8. Dalrymple, S. A., Lucian, L. A., Slattery, R., et al. (1995) Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect. Immun. 63, 2262 - 2268.

    PubMed  CAS  Google Scholar 

  9. Bernad, A., Kopf, M., Kulbacki, R., Weich, N., Koehler, G., and Gutierrez-Ramos, J. C. (1994) Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system. Immunity 1, 725 - 731.

    PubMed  CAS  Google Scholar 

  10. Houssiau, F. and Van Snick, J. (1992) IL6 and the T-cell response. Res. Immunol. 143, 740 - 743.

    PubMed  CAS  Google Scholar 

  11. Uyttenhove, C., Coulie, P. G., and Van Snick, J. (1988) T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor. J. Exp. Med. 167, 1417 - 1427.

    PubMed  CAS  Google Scholar 

  12. Lotz, M., Jirik, F., Kabouridis, P., et al. (1988) B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes. J. Exp. Med. 167, 1253 - 1258.

    PubMed  CAS  Google Scholar 

  13. Ramsay, A. J. and Kopf, M. (1998) IL-6 knockout mice. In: Durum, S., Kopf, M., and Muegge, K., ed. Cytokine Knockouts. Humana, Totowa, NJ, pp. 227 - 236.

    Google Scholar 

  14. Kopf, M., Herren, S., Wiles, M. V., Pepys, M. B., and Kosco-Vilbois, M. H. (1998) Interleukin 6 influences germinal center development and antibody production via a contribution of C3 complement component. J. Exp. Med. 188, 1895 - 1906.

    PubMed  CAS  Google Scholar 

  15. Ramsay, A. J., Ruby, J., and Ramshaw, I. A. (1993) A case for cytokines as effector molecules in the resolution of virus infection. Immunol. Today 14, 155 - 157.

    PubMed  CAS  Google Scholar 

  16. Kishimoto, T. and Hirano, T. (1988) Molecular regulation of B lymphocyte response. Annu. Rev. Immunol. 6, 485 - 512.

    PubMed  CAS  Google Scholar 

  17. Jourdan, M., Bataille, R., Seguin, J., Zhang, X. G., Chaptal, P. A., and Klein, B. (1990) Constitutive production of interleukin-6 and immunologic features in cardiac myxomas. Arthritis Rheum. 33, 398 - 402.

    PubMed  CAS  Google Scholar 

  18. Suematsu, S., Matsusaka, T., Matsuda, T., et al. (1992) Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice. Proc. Natl. Acad. Sci. USA 89, 232 - 235.

    PubMed  CAS  Google Scholar 

  19. Fattori, E., Della Rocca, C., Costa, P., et al. (1994) Development of progressive kidney damage and myeloma kidney in interleukin-6 transgenic mice. Blood 83, 2570 - 2579.

    PubMed  CAS  Google Scholar 

  20. Fischer, M. B., Ma, M., Goerg, S., et al. (1996) Regulation of the B cell response to T-dependent antigens by classical pathway complement. J. Immunol. 157, 549 - 556.

    PubMed  CAS  Google Scholar 

  21. La Flamme, A. C. and Pearce, E. J. (1999) The absence of IL-6 does not affect Th2 cell development in vivo, but does lead to impaired proliferation, IL-2 receptor expression, and B cell responses. J. Immunol. 162, 5829 - 5837.

    PubMed  Google Scholar 

  22. Alonzi, T., Fattori, E., Lazzaro, D., et al. (1998) Interleukin 6 is required for the development of collagen-induced arthritis. J. Exp. Med. 187, 461 - 468.

    PubMed  CAS  Google Scholar 

  23. Ohshima, S., Saeki, Y., Mima, T., et al. (1998) Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc. Natl. Acad. Sci. USA 95, 8222 - 8226.

    PubMed  CAS  Google Scholar 

  24. Sasai, M., Saeki, Y., Ohshima, S., et al. (1999) Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice. Arthritis Rheum. 42, 1635 - 1643.

    PubMed  CAS  Google Scholar 

  25. Boe, A., Baiocchi, M., Carbonatto, M., Papoian, R., and Serlupi-Crescenzi, O. (1999) Interleukin 6 knock-out mice are resistant to antigen-induced experimental arthritis. Cytokine 11, 1057 - 1064.

    PubMed  CAS  Google Scholar 

  26. Eugster, H. P., Frei, K., Kopf, M., Lassmann, H., and Fontana, A. (1998) IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 28, 2178 - 2187.

    PubMed  CAS  Google Scholar 

  27. Mendel, I., Katz, A., Kozak, N., Ben-Nun, A., and Revel, M. (1998) Interleukin-6 functions in autoimmune encephalomyelitis: a study in gene-targeted mice. Eur. J. Immunol. 28, 1727 - 1737.

    PubMed  CAS  Google Scholar 

  28. Okuda, Y., Sakoda, S., Bernard, C. C., et al. (1998) IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. Int. Immunol. 10, 703 - 708.

    PubMed  CAS  Google Scholar 

  29. Samoilova, E. B., Horton, J. L., Hilliard, B., Liu, T. S., and Chen, Y. (1998) IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 161, 6480 - 6486.

    PubMed  CAS  Google Scholar 

  30. Romani, L., Mencacci, A., Cenci, E., et al. (1996) Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J. Exp. Med. 183, 1345 - 1355.

    CAS  Google Scholar 

  31. Richards, H. B., Satoh, M., Shaw, M., Libert, C., Poli, V., and Reeves, W. H. (1998) Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus. J. Exp. Med. 188, 985 - 990.

    PubMed  CAS  Google Scholar 

  32. Brewer, J. M., Conacher, M., Gaffney, M., Douglas, M., Bluethmann, H., and Alexander, J. (1998) Neither interleukin-6 nor signalling via tumour necrosis factor receptor-1 contribute to the adjuvant activity of alum and Freund's adjuvant. Immunology 93, 41 - 48.

    PubMed  CAS  Google Scholar 

  33. Bromander, A. K., Ekman, L., Kopf, M., Nedrud, J. G., and Lycke, N. Y. (1996) IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection. J. Immunol. 156, 4290 - 4297.

    PubMed  CAS  Google Scholar 

  34. Ladel, C. H., Blum, C., Dreher, A., Reifenberg, K., Kopf, M., and Kaufmann, S. H. (1997) Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect. Immun. 65, 4843 - 4849.

    PubMed  CAS  Google Scholar 

  35. Markine-Goriaynoff, D., Nguyen, T. D., Bigaignon, G., Van Snick, J., and Coutelier, J. P. (2001) Distinct requirements for IL-6 in polyclonal and specific Ig production induced by microorganisms. Int. Immunol. 13, 1185 - 1192.

    PubMed  CAS  Google Scholar 

  36. Ramsay, A. J., Husband, A. J., Ramshaw, I. A., et al. (1994) The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264, 561 - 563.

    PubMed  CAS  Google Scholar 

  37. Beagley, K. W., Bao, S., Ramsay, A. J., Eldridge, J. H., and Husband, A. J. (1995) IgA production by peritoneal cavity B cells is IL-6 independent: implications for intestinal IgA responses. Eur. J. Immunol. 25, 2123 - 2126.

    PubMed  CAS  Google Scholar 

  38. Bao, S., Husband, A. J., and Beagley, K. W. (1999) B1 B cell numbers and antibodies against phosphorylcholine and LPS are increased in IL-6 gene knockout mice. Cell Immunol. 198, 139 - 142.

    PubMed  CAS  Google Scholar 

  39. VanCott, J. L., Franco, M. A., Greenberg, H. B., et al. (2000) Protective immunity to rotavirus shedding in the absence of interleukin-6: Thl cells and immunoglobulin A develop normally. J. Virol. 74, 5250 - 5256.

    PubMed  CAS  Google Scholar 

  40. Suzuki, Y., Rani, S., Liesenfeld, O., et al. (1997) Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice. Infect. Immun. 65, 2339 - 2345.

    PubMed  CAS  Google Scholar 

  41. Jebbari, H., Roberts, C. W., Ferguson, D. J., Bluethmann, H., and Alexander, J. (1998) A protective role for IL-6 during early infection with Toxoplasma gondii. Parasite Immunol. 20, 231 - 239.

    CAS  Google Scholar 

  42. Williams, D. M., Grubbs, B. G., Darville, T., Kelly, K., and Rank, R. G. (1998) A role for interleukin-6 in host defense against murine Chlamydia trachomatis infection. Infect. Immun. 66, 4564 - 4567.

    PubMed  CAS  Google Scholar 

  43. Saunders, B. M., Frank, A. A., Orme, I. M., and Cooper, A. M. (2000) Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection. Infect. Immun. 68, 3322 - 3326.

    PubMed  CAS  Google Scholar 

  44. Cenci, E., Mencacci, A., Casagrande, A., Mosci, P., Bistoni, F., and Romani, L. (2001) Impaired antifungal effector activity but not inflammatory cell recruitment in interleukin-6-deficient mice with invasive pulmonary aspergillosis. J. Infect. Dis. 184, 610 - 617.

    PubMed  CAS  Google Scholar 

  45. Anguita, J., Rincon, M., Samanta, S., Barthold, S. W., Flavell, R. A., and Fikrig, E. (1998) Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased Lyme arthritis. J. Infect. Dis. 178, 1512 - 1515.

    PubMed  CAS  Google Scholar 

  46. Dalrymple, S. A., Slattery, R., Aud, D. M., Krishna, M., Lucian, L. A., and Murray, R. (1996) Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection. Infect. Immun. 64, 3231 - 3235

    PubMed  CAS  Google Scholar 

  47. van Enckevort, F. H., Sweep, C. G., Span, P. N., Netea, M. G., Hermus, A. R., and Kullberg, B. J. (2001) Reduced adrenal response and increased mortality after systemic Klebsiella pneumoniae infection in interleukin-6-deficient mice. Eur. Cytokine Netw. 12, 581 - 586.

    PubMed  Google Scholar 

  48. Moskowitz, N. H., Brown, D. R., and Reiner, S. L. (1997) Efficient immunity against Leishmania major in the absence of interleukin-6. Infect. Immun. 65, 2448 - 2450.

    PubMed  CAS  Google Scholar 

  49. Titus, R. G., DeKrey, G. K., Morris, R. V., and Soares, M. B. (2001) Interleukin-6 deficiency influences cytokine expression in susceptible BALB mice infected with Leishmania major but does not alter the outcome of disease. Infect. Immun. 69, 5189 - 5192.

    PubMed  CAS  Google Scholar 

  50. Mabbott, N. A., Williams, A., Farquhar, C. F., Pasparakis, M., Kollias, G., and Bruce, M. E. (2000) Tumor necrosis factor alpha-deficient, but not interleukin-6-deficient, mice resist peripheral infection with scrapie. J. Virol. 74, 3338 - 3344.

    PubMed  CAS  Google Scholar 

  51. Feldmann, M., Brennan, F. M., and Maini, R. N. (1996) Rheumatoid arthritis. Cell 85, 307 - 310.

    CAS  Google Scholar 

  52. Houssiau, F. A., Devogelaer, J. P., Van Damme, J., de Deuxchaisnes, C. N., and Van Snick, J. (1988) Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 31, 784 - 788.

    PubMed  CAS  Google Scholar 

  53. De Benedetti, F., Massa, M., Robbioni, P., Ravelli, A., Burgio, G. R., and Martini, A. (1991) Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum. 34, 1158 - 1163.

    PubMed  Google Scholar 

  54. Romano, M., Sironi, M., Toniatti, C., et al. (1997) Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 6, 315 - 325.

    PubMed  CAS  Google Scholar 

  55. Mihara, M., Moriya, Y., Kishimoto, T., and Ohsugi, Y. (1995) Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor. Br. J. Rheumatol. 34, 321 - 325.

    PubMed  CAS  Google Scholar 

  56. Tamura, T., Udagawa, N., Takahashi, N., et al. (1993) Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc. Natl. Acad. Sci. USA 90, 11924 - 11928.

    PubMed  CAS  Google Scholar 

  57. Trentham, D. E., Townes, A. S., and Kang, A. H. (1977) Autoimmunity to type II collagen an experimental model of arthritis. J. Exp. Med. 146, 857 - 868.

    PubMed  CAS  Google Scholar 

  58. Brackertz, D., Mitchell, G. F., and Mackay, I. R. (1977) Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice. Arthritis Rheum. 20, 841 - 8450.

    PubMed  CAS  Google Scholar 

  59. Keystone, E. C., Schorlemmer, H. U., Pope, C., and Allison, A. C. (1977) Zymosan-induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway of complement. Arthritis Rheum. 20, 1396 - 1401.

    PubMed  CAS  Google Scholar 

  60. Kobayashi, H., Ohshima, S., Nishioka, K., et al. (2002) Antigen induced arthritis (AIA) can be transferred by bone marrow transplantation: evidence that interleukin 6 is essential for induction of AIA. J. Rheumatol. 29, 1176 - 1182.

    PubMed  CAS  Google Scholar 

  61. van de Loo, F. A., Arntz, O. J., and Van den Berg, W. B. (1997) Effect of interleukin 1 and leukaemia inhibitory factor on chondrocyte metabolism in articular cartilage from normal and interleukin-6-deficient mice: role of nitric oxide and IL-6 in the suppression of proteoglycan synthesis. Cytokine 9, 453 - 462.

    PubMed  Google Scholar 

  62. de Hooge, A. S., van De Loo, F. A., Arntz, O. J., and van Den Berg, W. B. (2000) Involvement of IL-6, apart from its role in immunity, in mediating a chronic response during experimental arthritis. Am. J. Pathol. 157, 2081 - 2091.

    PubMed  Google Scholar 

  63. Kerlero de Rosbo, N., Milo, R., Lees, M. B., Burger, D., Bernard, C. C., and Ben-Nun, A. (1993) Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J. Clin. Invest. 92, 2602 - 2608.

    Google Scholar 

  64. Mendel, I., Kerlero de Rosbo, N., and Ben-Nun, A. (1995) A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 25, 1951 - 1959.

    PubMed  CAS  Google Scholar 

  65. Eugster, H. P., Frei, K., Winkler, F., et al. (2001) Superantigen overcomes resistance of IL-6deficient mice towards MOG-induced EAE by a TNFR1 controlled pathway. Eur. J. Immunol. 31, 2302 - 2312.

    PubMed  CAS  Google Scholar 

  66. Campbell, I. L., Abraham, C. R., Masliah, E., et al. (1993) Neurologic disease induced in trans-genic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. USA 90, 10061 - 10065.

    PubMed  CAS  Google Scholar 

  67. Raisz, L. G. (1988) Local and systemic factors in the pathogenesis of osteoporosis. N. Engl. J. Med. 318, 818 - 828.

    PubMed  CAS  Google Scholar 

  68. Horowitz, M. C. (1993) Cytokines and estrogen in bone: anti-osteoporotic effects. Science 260, 626 - 627.

    PubMed  CAS  Google Scholar 

  69. Bellido, T., Jilka, R. L., Boyce, B. F., et al. (1995) Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. J. Clin. Invest. 95, 2886 - 2895.

    PubMed  CAS  Google Scholar 

  70. Klein, B., Zhang, X. G., Lu, Z. Y., and Bataille, R. (1995) Interleukin-6 in human multiple myeloma. Blood 85, 863 - 872.

    PubMed  CAS  Google Scholar 

  71. Klein, B., Wijdenes, J., Zhang, X. G., et al. (1991) Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood 78, 1198 - 1204.

    PubMed  CAS  Google Scholar 

  72. Potter, M., and Wiener, F. (1992) Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations. Carcinogenesis 13, 1681 - 1697.

    PubMed  CAS  Google Scholar 

  73. Degrassi, A., Hilbert, D. M., Rudikoff, S., Anderson, A. O., Potter, M., and Coon, H. G. (1993) In vitro culture of primary plasmacytomas requires stromal cell feeder layers. Proc. Natl. Acad. Sci. USA 90, 2060 - 2064.

    PubMed  CAS  Google Scholar 

  74. Dedera, D. A., Urashima, M., Chauhan, D., LeBrun, D. P., Bronson, R. T., and Anderson, K. C. (1996) Interleukin-6 is required for pristane-induced plasma cell hyperplasia in mice. Br. J. Haematol. 94, 53 - 61.

    PubMed  CAS  Google Scholar 

  75. Screpanti, I., Musiani, P., Bellavia, D., et al. (1996) Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient mice. J. Exp. Med. 184, 1561 - 1566.

    PubMed  CAS  Google Scholar 

  76. Lattanzio, G., Libert, C., Aquilina, M., et al. (1997) Defective development of pristane-oilinduced plasmacytomas in interleukin-6-deficient BALB/c mice. Am. J. Pathol. 151, 689 - 696.

    PubMed  CAS  Google Scholar 

  77. Hilbert, D. M., Kopf, M., Mock, B. A., Kohler, G., and Rudikoff, S. (1995) Interleukin 6 is essential for in vivo development of B lineage neoplasms. J. Exp. Med. 182, 243 - 248.

    PubMed  CAS  Google Scholar 

  78. Hilbert, D. M., Migone, T. S., Kopf, M., Leonard, W. J., and Rudikoff, S. (1996) Distinct tumori-genic potential of abl and raf in B cell neoplasia: abl activates the IL-6 signaling pathway. Immunity 5, 81 - 89.

    PubMed  CAS  Google Scholar 

  79. Fausto, N. (2000) Liver regeneration. J. Hepatol. 32, 19 - 31.

    PubMed  CAS  Google Scholar 

  80. Maione, D., Di Carlo, E., Li, W., et al. (1998) Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver. EMBO J. 17, 5588 - 5597.

    PubMed  CAS  Google Scholar 

  81. Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., et al. (1996) Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274, 1379 - 1383.

    PubMed  CAS  Google Scholar 

  82. Sakamoto, T., Liu, Z., Murase, N., et al. (1999) Mitosis and apoptosis in the liver of interleukin-6deficient mice after partial hepatectomy. Hepatology 29, 403 - 411.

    PubMed  CAS  Google Scholar 

  83. Ledda-Columbano, G. M., Curto, M., Piga, R., et al. (1998) In vivo hepatocyte proliferation is inducible through a TNF and IL-6-independent pathway. Oncogene 17, 1039-1044.

    Google Scholar 

  84. Li, W., Liang, X., Leu, J. I., Kovalovich, K., Ciliberto, G., and Taub, R. (2001) Global changes in interleukin-6-dependent gene expression patterns in mouse livers after partial hepatectomy. Hepatology 33, 1377 - 1386.

    PubMed  CAS  Google Scholar 

  85. Kovalovich, K., DeAngelis, R. A., Li, W., Furth, E. E., Ciliberto, G., and Taub, R. (2000) Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology 31, 149 - 159.

    PubMed  CAS  Google Scholar 

  86. Katz, A., Chebath, J., Friedman, J., and Revel, M. (1998) Increased sensitivity of IL-6-deficient mice to carbon tetrachloride hepatotoxicity and protection with an IL-6 receptor-IL-6 chimera. Cytokines Cell. Mol. Ther. 4, 221 - 227.

    PubMed  CAS  Google Scholar 

  87. Ezure, T., Sakamoto, T., Tsuji, H., et al. (2000) The development and compensation of biliary cirrhosis in interleukin-6-deficient mice. Am. J. Pathol. 156, 1627 - 1639.

    PubMed  CAS  Google Scholar 

  88. Camargo, C. A., Jr., Madden, J. F., Gao, W., Selvan, R. S., and Clavien, P. A. (1997) Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 26, 1513 - 1520.

    PubMed  CAS  Google Scholar 

  89. Kushner, I. (1982) The phenomenon of the acute phase response. Ann. NYAcad. Sci. 389, 39 - 48.

    CAS  Google Scholar 

  90. Won, K., Campos, S.P., and Baumann, H. (1993) Experimental systems for studying hepatic acute phase response. In: Mackiewicz, A., Kushner, I., and Baumann, H., ed. Acute Phase Protein. CRC Press, Boca Raton FL, pp. 255 - 271.

    Google Scholar 

  91. Koj, A., Gauldie, J., and Baumann, H. (1993) Biological perspectives of cytokine and hormone networks. In: Mackiewicz, A., Kushner, I., and Baumann, H., ed. Acute Phase Protein. CRC Press, Boca Raton, FL, pp. 275 - 287.

    Google Scholar 

  92. Beutler, B., Milsark, I. W., and Cerami, A. C. (1985) Passive immunization against cachectin/ tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229, 869 - 871.

    PubMed  CAS  Google Scholar 

  93. Zetterstrom, M., Sundgren-Andersson, A. K., Ostlund, P., and Bartfai, T. (1998) Delineation of the proinflammatory cytokine cascade in fever induction. Ann. NYAcad. Sci. 856, 48 - 52.

    CAS  Google Scholar 

  94. Fattori, E., Cappelletti, M., Costa, P., et al. (1994) Defective inflammatory response in interleukin 6-deficient mice. J. Exp. Med. 180, 1243 - 1250.

    PubMed  CAS  Google Scholar 

  95. Xing, Z., Gauldie, J., Cox, G., et al. (1998) IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 101, 311 - 320.

    PubMed  CAS  Google Scholar 

  96. Baumann, H., Ziegler, S. F., Mosley, B., Morella, K. K., Pajovic, S., and Gearing, D. P. (1993) Reconstitution of the response to leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in hepatoma cells. J. Biol. Chem. 268, 8414 - 8417.

    PubMed  CAS  Google Scholar 

  97. Alonzi, T., Fattori, E., Cappelletti, M., Ciliberto, G., and Poli, V. (1998) Impaired Stat3 activation following localized inflammatory stimulus in IL-6-deficient mice. Cytokine 10, 13 - 18.

    PubMed  CAS  Google Scholar 

  98. Alonzi, T., Maritano, D., Gorgoni, B., Rizzuto, G., Libert, C., and Poli, V. (2001) Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver. Mol. Cell Biol. 21, 1621 - 1632.

    PubMed  CAS  Google Scholar 

  99. Libert, C., Takahashi, N., Cauwels, A., Brouckaert, P., Bluethmann, H., and Fiers, W. (1994) Response of interleukin-6-deficient mice to tumor necrosis factor-induced metabolic changes and lethality. Eur. J. Immunol. 24, 2237 - 2242.

    PubMed  CAS  Google Scholar 

  100. Benigni, F., Fantuzzi, G., Sacco, S., et al. (1996) Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1. Blood 87, 1851 - 1854.

    PubMed  CAS  Google Scholar 

  101. Kozak, W., Kluger, M. J., Soszynski, D., et al. (1998) IL-6 and IL-1 beta in fever. Studies using cytokine-deficient (knockout) mice. Ann. NY Acad. Sci. 856, 33 - 47.

    PubMed  CAS  Google Scholar 

  102. Manfredi, B., Sacerdote, P., Gaspani, L., Poli, V., and Panerai, A. E. (1998) IL-6 knock-out mice show modified basal immune functions, but normal immune responses to stress. Brain Behay. Immun. 12, 201 - 211.

    CAS  Google Scholar 

  103. Bethin, K. E., Vogt, S. K., and Muglia, L. J. (2000) Interleukin-6 is an essential, corticotropinreleasing hormone-independent stimulator of the adrenal axis during immune system activation. Proc. Natl. Acad. Sci. USA 97, 9317 - 9322.

    PubMed  CAS  Google Scholar 

  104. Venihaki, M., Dikkes, P., Carrigan, A., and Karalis, K. P. (2001) Corticotropin-releasing hormone regulates IL-6 expression during inflammation. J. Clin. Invest. 108, 1159 - 1166.

    PubMed  CAS  Google Scholar 

  105. Andersson, B., Jobin, M., and Olsson, K. (1966) Serotonin and temperature control. Acta Physiol. Scand. 67, 50 - 56.

    PubMed  CAS  Google Scholar 

  106. Kozak, W., Poli, V., Soszynski, D., Conn, C. A., Leon, L. R., and Kluger, M. J. (1997) Sickness behavior in mice deficient in interleukin-6 during turpentine abscess and influenza pneumonitis. Am. J. Physiol. 272, R621 - R630.

    PubMed  CAS  Google Scholar 

  107. Chai, Z., Gatti, S., Toniatti, C., Poli, V., and Bartfai, T. (1996) Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice. J. Exp. Med. 183, 311 - 316.

    PubMed  CAS  Google Scholar 

  108. Leon, L. R., White, A. A., and Kluger, M. J. (1998) Role of IL-6 and TNF in thermoregulation and survival during sepsis in mice. Am. J. Physiol. 275, R269 - R277.

    PubMed  CAS  Google Scholar 

  109. Jones, S. A., Novick, D., Horiuchi, S., Yamamoto, N., Szalai, A. J., and Fuller, G. M. (1999) C-reactive protein: a physiological activator of interleukin 6 receptor shedding. J. Exp. Med. 189, 599 - 604.

    PubMed  CAS  Google Scholar 

  110. Di Santo, E., Alonzi, T., Poli, V., et al. (1997) Differential effects of IL-6 on systemic and central production of TNF: a study with IL-6-deficient mice. Cytokine 9, 300 - 306.

    PubMed  Google Scholar 

  111. Di Santo, E., Alonzi, T., Fattori, E., et al. (1996) Overexpression of interleukin-6 in the central nervous system of transgenic mice increases central but not systemic proinflammatory cytokine production. Brain Res. 740, 239 - 244.

    PubMed  Google Scholar 

  112. Penkowa, M., Moos, T., Carrasco, J., et al. (1999) Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice. Glia 25, 343 - 357.

    PubMed  CAS  Google Scholar 

  113. Penkowa, M., Giralt, M., Carrasco, J., Hadberg, H., and Hidalgo, J. (2000) Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6deficient mice. Glia 32, 271 - 285.

    PubMed  CAS  Google Scholar 

  114. Swartz, K. R., Liu, F., Sewell, D., et al. (2001) Interleukin-6 promotes post-traumatic healing in the central nervous system. Brain Res. 896, 86 - 95.

    PubMed  CAS  Google Scholar 

  115. Klein, M. A., Moller, J. C., Jones, L. L., Bluethmann, H., Kreutzberg, G. W., and Raivich, G. (1997) Impaired neuroglial activation in interleukin-6 deficient mice. Glia 19, 227 - 233.

    PubMed  CAS  Google Scholar 

  116. Murphy, P. G., Borthwick, L. S., Johnston, R. S., Kuchel, G., and Richardson, P. M. (1999) Nature of the retrograde signal from injured nerves that induces interleukin-6 mRNA in neurons. J. Neurosci. 19, 3791 - 3800.

    Google Scholar 

  117. Galiano, M., Liu, Z. Q., Kalla, R., et al. (2001) Interleukin-6 (IL6) and cellular response to facial nerve injury: effects on lymphocyte recruitment, early microglial activation and axonal outgrowth in IL6-deficient mice. Eur. J. Neurosci. 14, 327 - 341.

    PubMed  CAS  Google Scholar 

  118. Zhong, J., Dietzel, I. D., Wahle, P., Kopf, M., and Heumann, R. (1999) Sensory impairments and delayed regeneration of sensory axons in interleukin-6-deficient mice. J. Neurosci. 19, 4305 - 4313.

    PubMed  CAS  Google Scholar 

  119. Xu, X. J., Hao, J. X., Andell-Jonsson, S., Poli, V., Bartfai, T., and Wiesenfeld-Hallin, Z. (1997) Nociceptive responses in interleukin-6-deficient mice to peripheral inflammation and peripheral nerve section. Cytokine 9, 1028 - 1033.

    PubMed  CAS  Google Scholar 

  120. Bianchi, M., Maggi, R., Pimpinelli, F., et al. (1999) Presence of a reduced opioid response in interleukin-6 knock out mice. Eur. J. Neurosci. 11, 1501 - 1507.

    PubMed  CAS  Google Scholar 

  121. Wallenius, V., Wallenius, K., Ahren, B., et al. (2002) Interleukin-6-deficient mice develop mature-onset obesity. Nat. Med. 8, 75 - 79.

    PubMed  CAS  Google Scholar 

  122. Lyons, R. E., Anthony, J. P., Ferguson, D. J., et al. (2001) Immunological studies of chronic ocular toxoplasmosis: up-regulation of major histocompatibility complex class I and transforming growth factor beta and a protective role for interleukin-6. Infect. Immun. 69, 2589 - 2595.

    PubMed  CAS  Google Scholar 

  123. Fenton, R. R., Molesworth-Kenyon, S., Oakes, J. E., and Lausch, R. N. (2002) Linkage of IL-6 with neutrophil chemoattractant expression in virus-induced ocular inflammation. Invest. Ophthalmol. Vis. Sci. 43, 737 - 743.

    PubMed  Google Scholar 

  124. van Enckevort, F. H., Netea, M. G., Hermus, A. R., et al. (1999) Increased susceptibility to systemic candidiasis in interleukin-6 deficient mice. Med. Mycol. 37, 419 - 426.

    PubMed  Google Scholar 

  125. van der Poll, T., Keogh, C. V., Guirao, X., Buurman, W. A., Kopf, M., and Lowry, S. F. (1997) Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J. Infect. Dis. 176, 439 - 444.

    PubMed  Google Scholar 

  126. Balto, K., Sasaki, H., and Stashenko, P. (2001) Interleukin-6 deficiency increases inflammatory bone destruction. Infect. Immun. 69, 744 - 750.

    PubMed  CAS  Google Scholar 

  127. Wang, J., Homer, R. J., Chen, Q., and Elias, J. A. (2000) Endogenous and exogenous IL-6 inhibit aeroallergen-induced Th2 inflammation. J. Immunol. 165, 4051 - 4061.

    PubMed  CAS  Google Scholar 

  128. Leemans, J. C., Vervoordeldonk, M. J., Florquin, S., Van Kessel, K. P., and Van Der Poll, T. (2002) Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus. Am. J. Respir. Crit. Care Med. 165, 1445 - 1450.

    Google Scholar 

  129. Rijneveld, A. W., van den Dobbelsteen, G. P., Florquin, S., et al. (2002) Roles of interleukin-6 and macrophage inflammatory protein-2 in pneumolysin-induced lung inflammation in mice. J. Infect. Dis. 185, 123 - 126.

    PubMed  CAS  Google Scholar 

  130. Rosenbaum, J. T., Kievit, P., Han, Y. B., Park, J. M., and Planck, S. R. (1998) Interleukin-6 does not mediate endotoxin-induced uveitis in mice: studies in gene deletion animals. Invest. Ophthalmol. Vis. Sci. 39, 64 - 69.

    PubMed  CAS  Google Scholar 

  131. Hurst, S. M., Wilkinson, T. S., McLoughlin, R. M., et al. (2001) Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 14, 705 - 714.

    PubMed  CAS  Google Scholar 

  132. Cuzzocrea, S., De Sarro, G., Costantino, G., et al. (1999) IL-6 knock-out mice exhibit resistance to splanchnic artery occlusion shock. J. Leukoc. Biol. 66, 471 - 480.

    PubMed  CAS  Google Scholar 

  133. Meng, Z. H., Dyer, K., Billiar, T. R., and Tweardy, D. J. (2001) Essential role for IL-6 in post-resuscitation inflammation in hemorrhagic shock. Am. J. Physiol. Cell. Physiol. 280, C343 - C351.

    PubMed  CAS  Google Scholar 

  134. Cuzzocrea, S., Sautebin, L., De Sano, G., et al. (1999) Role of IL-6 in the pleurisy and lung injury caused by carrageenan. J. Immunol. 163, 5094 - 5104.

    PubMed  CAS  Google Scholar 

  135. Cuzzocrea, S., de Sarro, G., Costantino, G., et al. (1999) Role of interleukin-6 in a non-septic shock model induced by zymosan. Eur. Cytokine Netw. 10, 191 - 203.

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Poli, V., Maritano, D. (2003). IL-6 Knockout Mice. In: Fantuzzi, G. (eds) Cytokine Knockouts. Contemporary Immunology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-405-4_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-405-4_13

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-415-9

  • Online ISBN: 978-1-59259-405-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics